Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|February 18, 2011
Combination lipid therapy in type 2 diabetes mellitusBruno VergèsFundamental & Clinical Pharmacology|August 5, 2009
Lipid modification in type 2 diabetes: the role of LDL and HDLBruno VergèsCurrent Opinion in Lipidology|November 11, 2006
Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELDBruno VergèsCurrent Opinion in Lipidology|November 9, 2005
Role for fibrate therapy in diabetes: evidence before FIELDBruno VergèsAtherosclerosis|June 27, 2023
Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological dataBruno VergèsLa Revue Du Praticien|January 12, 2016
[TREATMENT OF TYPE 2 DIABETES IN PATIENTS WITH HISTORY OF CARDIOVASCULAR DISEASE]Bruno VergèsDiabetes & Metabolism|September 30, 2020
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanismsBruno VergèsFundamental & Clinical Pharmacology|November 16, 2007
Effects of glitazones in the treatment of diabetes and/or hyperlipidaemia: glycaemic control and plasma lipid levelsBruno VergèsPageof 16